These results are consistent with the present study and are further supported by evidence from the TOPCAT28 and EMPEROR‐Preserved29 trials, which additionally observed that low albumin levels were associated with greater arterial stiffness, diastolic dysfunction, pulmonary hypertension, and biomarkers indicative of inflammation and liver fibrosis.28, 29. This evidence concerns the gene ALB and pulmonary arterial hypertension.